Seton Securities Group has been shorting small-cap companies such as OpenCell BioMed, Inc. (OCBM.OB) and Tri-Star Holdings, Inc. (TSHL.PK). Today we attempted to speak directly to Seton Securities’ President regarding this issue, but he declined to provide any details of the SEC ongoing investigation of the shorting of stocks and wouldn’t comment on the possibility of the SEC requesting records or other information from his company or others that are continuing to short stocks.

He even declined to give his full name. However, he did say they have not heard from federal investigators and have “no comment” regarding the shorting of stocks.

In mid-September, the SEC announced that would be expanding their ongoing investigation into possible market manipulation. SEC Chairman Christopher Cox stated, “Investors have a right to know that the rule of law is being enforced and that our capital markets are not being manipulated. We are working together with our

Laura Cadden has found a small cap biotech company with huge growth potential. OpenCell BioMed Inc. (OTC:OCBM) is hoping to revolutionize dental surgery using titanium to help fix implants. Laura says investors willing to take on a risky venture could win big with ‘early-mover’ profits.

More from Today’s Financial News:

What is found in everything from pyrotechnics to toothpaste, golf clubs to spacecraft, horseshoes to joint replacements? One word… titanium.

An incredibly versatile, lightweight-yet-strong, corrosion-resistant mineral, titanium is often alloyed with other metals with beneficial results such as lowering carbon content (stainless steel) or to harden (copper).

And it’s just as good with human bone and tissue.

One of the most exciting uses of the metal is in the medical field due to its ability to osseointegrate (human bone actually integrates with it).

This growth anchors titanium medical implants to the degree that they may remain in place for up to 20 years!

Putting their money